MEI Pharma (MEIP)
(Delayed Data from NSDQ)
$2.86 USD
-0.09 (-3.05%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $2.93 +0.07 (2.45%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | NA |
EPS Last Quarter | -1.13 |
Last EPS Surprise | 23.65% |
ABR | 3.00 |
Earnings ESP
|
NA |
---|---|
Current Year | -5.10 |
Next Year | -3.71 |
EPS (TTM) | 4.30 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (6/2025) |
Next Year (6/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 12.50M | 25.00M |
# of Estimates | NA | NA | 1 | 1 |
High Estimate | NA | NA | 12.50M | 25.00M |
Low Estimate | NA | NA | 12.50M | 25.00M |
Year ago Sales | 65.30M | 0.00M | 65.30M | 12.50M |
Year over Year Growth Est. | NA | NA | -80.86% | 100.00% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (6/2025) |
Next Year (6/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | -5.10 | -3.71 |
# of Estimates | NA | NA | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | NA | NA | -5.10 | -3.71 |
Low Estimate | NA | NA | -5.10 | -3.71 |
Year ago EPS | 8.46 | -1.66 | 4.30 | -5.10 |
Year over Year Growth Est. | NA | NA | -218.60% | 27.25% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (6/2025) |
Next Year (6/2026) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | 0 | 0 |
Up Last 30 Days | NA | NA | 0 | 0 |
Up Last 60 Days | NA | NA | 0 | 0 |
Down Last 7 Days | NA | NA | 0 | 0 |
Down Last 30 Days | NA | NA | 0 | 0 |
Down Last 60 Days | NA | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (6/2025) |
Next Year (6/2026) |
|
---|---|---|---|---|
Current | NA | NA | -5.10 | -3.71 |
7 Days Ago | NA | NA | -5.10 | -3.71 |
30 Days Ago | -1.70 | -2.20 | -5.10 | -3.71 |
60 Days Ago | -1.70 | -2.20 | -5.10 | -3.71 |
90 Days Ago | -1.70 | -2.20 | -5.10 | -3.71 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (6/2025) |
Next Year (6/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | -5.10 | -3.71 |
Zacks Consensus Estimate | NA | NA | -5.10 | -3.71 |
Earnings ESP | NA | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.13 | -1.37 | -1.66 | 8.46 | NA |
Estimate | -1.48 | -1.38 | -1.46 | -1.47 | NA |
Difference | 0.35 | 0.01 | -0.20 | 9.93 | 2.52 |
Surprise | 23.65% | 0.72% | -13.70% | 675.51% | 171.55% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more